Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.
What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

Read More

Overview

Feature Articles

Latest Rheumatoid Arthritis News and Research

Machine learning algorithm decodes immune system’s hidden data for disease detection

Machine learning algorithm decodes immune system’s hidden data for disease detection

Aging isn’t just in your genes—your environment plays a bigger role, study shows

Aging isn’t just in your genes—your environment plays a bigger role, study shows

An Arm and a Leg: How do you deal with wild drug prices?

An Arm and a Leg: How do you deal with wild drug prices?

E64FC26 inhibits inflammation and joint destruction in rheumatoid arthritis models

E64FC26 inhibits inflammation and joint destruction in rheumatoid arthritis models

Targeting ELK3 could offer new therapy for rheumatoid arthritis

Targeting ELK3 could offer new therapy for rheumatoid arthritis

Dysregulation of RNA-binding proteins in rheumatoid arthritis and osteoarthritis

Dysregulation of RNA-binding proteins in rheumatoid arthritis and osteoarthritis

Granzyme K identified as key trigger of complement system in autoimmune diseases

Granzyme K identified as key trigger of complement system in autoimmune diseases

New compound shows promise for treating psoriasis with blue light activation

New compound shows promise for treating psoriasis with blue light activation

Key information to consider before getting breast implants

Key information to consider before getting breast implants

Food safety tips to keep illness at bay

Food safety tips to keep illness at bay

AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs

AGA releases updated guidelines on hepatitis B reactivation in patients on immunosuppressive drugs

Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation

Granzyme K+ CD8+ T-cells identified as key drivers of recurrent airway inflammation

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Wearable devices can identify and predict flare-ups in inflammatory bowel disease

Wearable devices can identify and predict flare-ups in inflammatory bowel disease

Dexter software platform reveals connection between early life trauma and immune disorders

Dexter software platform reveals connection between early life trauma and immune disorders

Mayo Clinic partners with Microsoft Research and Cerebras to revolutionize AI in healthcare

Mayo Clinic partners with Microsoft Research and Cerebras to revolutionize AI in healthcare

A new strategy for enhancing the production of protein-based drugs

A new strategy for enhancing the production of protein-based drugs

Proteomic mapping identifies biomarkers driving healthy aging and preventing chronic diseases

Proteomic mapping identifies biomarkers driving healthy aging and preventing chronic diseases

Gut microbiome dynamics reveal key factors influencing Enterobacteriaceae colonization

Gut microbiome dynamics reveal key factors influencing Enterobacteriaceae colonization

AI-based method predicts progression of autoimmune diseases

AI-based method predicts progression of autoimmune diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.